Home » Topics » Regulatory

Regulatory
RSS

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

Ono announces new Japanese approvals for Opdivo

Aug. 22, 2018

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Aug. 17, 2018

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Aug. 16, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

FDA approves Arakoda for prevention of malaria

Aug. 10, 2018

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Aug. 10, 2018

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Aug. 9, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...